New drug combo shows promise for Hard-to-Treat cancers
Disease control
Recruiting now
This study is testing an experimental drug called NUC-7738, given alone or with another drug (pembrolizumab), in people with advanced solid tumors or lymphoma that have not responded to other treatments. The goal is to find the safest dose and see if it can shrink tumors or slow …
Phase: PHASE1, PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated May 14, 2026 12:03 UTC